UT MD Anderson Cancer Center

06/04/2026

Finding the right therapist can be tough, but the right fit can make all the difference.

Clinical psychologist Dr. Catherine Powers and psychiatrist Dr. Erica Taylor share a few tips on finding a therapist that works for you.

Read more: http://spr.ly/6007B8UmwV

Clinical psychologist Catherine Powers, Ph.D., and psychiatrist Erica Taylor, M.D., share three tips on how to find the right therapist for you.

06/04/2026

Construction is now halfway complete on our new Sugar Land campus, set to be finished in 2028.

The new location will include many clinical services, along with a new ambulatory surgery center and expanded modalities for diagnostic imaging, radiation oncology, and outpatient procedural services.

We look forward to providing our expert care to more patients in the Sugar Land community.

06/03/2026

Lymph nodes can swell for many reasons including infection or, in some cases, cancer. Swollen lymph nodes under your collarbone could be a sign of several different cancers.

Dr. Luis Fayad shares symptoms to look for and when to see a doctor. http://spr.ly/6004B8mQ3u

A swollen supraclavicular lymph node could be due to cancer or several other health conditions. Lymphoma specialist Luis Fayad, M.D., explains possible causes of this symptom, as well as questions to ask and when to see a doctor.

06/02/2026

Elastography is a non-invasive test that is often used to detect liver disease. The more stiffness found, the more likely the liver is to have fibrosis.

Learn more about elastography testing and how it helps diagnose liver disease. http://spr.ly/6002B8Y5hi

Elastography is a test that checks the stiffness of your liver. It's used to help diagnose liver fibrosis and treat it before it progresses to life-threatening liver disease. Leonardo Marcal, M.D., explains the procedure, including how to prepare and what your results mean.

06/01/2026

After donating blood for the first time in high school, Alizabeth Johnson continued giving regularly and even donated blood for a neighbor who needed a transfusion during cancer treatment.

Years later, Johnson became the caregiver for her mother with cancer. She saw firsthand how blood transfusions can save lives after her mom was treated at UT MD Anderson.

Now, Johnson encourages everyone to donate.

Read more of her story. http://spr.ly/6000B8iyEk

05/31/2026

After a pancreatic cancer diagnosis put his retirement travel plans on hold, Steve Wallace did not know if he would get the chance to return to the adventures he and his wife had planned. Today, he is preparing for a Caribbean cruise after participating in a clinical trial of daraxonrasib at UT MD Anderson.

Results from the phase 3 study, presented today at the 2026 ASCO Annual Meeting, showed the RAS(ON) inhibitor doubled survival compared with chemotherapy in previously treated pancreatic cancer.

“This is what makes these advances so meaningful,” says our Dr. Shubham Pant. “We are seeing patients regain quality of life and get back to the activities they enjoy.”

Read Steve’s story: http://spr.ly/6188B8gUMp

Daraxonrasib improved symptoms enough that some patients could resume ​activities they had previously abandoned and a new benchmark for treating the deadly cancer.

05/31/2026

Lung cancer treatment is advancing, with combination therapies offering a more personalized approach to treatment.

Drs. Lauren Byers and Ferdinandos Skoulidis discuss how targeted therapy and immunotherapy are being used together to improve outcomes.

They also highlight major progress in KRAS research and a few treatment approaches that may reduce the need for traditional chemotherapy.

Listen to the full Cancerwise podcast episode here or wherever you get your podcasts: http://spr.ly/6185B8jDV3

05/30/2026

Stacy Dixon’s second melanoma diagnosis was more complex than her first. Instead of removing a single small mole, doctors recommended brain surgery to remove stage 4 tumors.

That’s when she turned to UT MD Anderson, where she found a new treatment path through a clinical trial.

Stacy has since been cancer-free and says she would do it all again.

Dr. Jeffrey Weinberg presented the findings of this clinical trial during the American Society of Clinical Oncology Annual Meeting. You can read more about Stacy’s diagnosis and the brachytherapy treatment trial here: http://spr.ly/6001B8do1N

Stage 4 melanoma survivor Stacy Dixon joined a clinical trial for a new, tile-based form of brachytherapy back in 2022. That technology could change the standard of care for patients with brain metastases forever.

05/29/2026

Nearly all new drugs go through a clinical trial process, starting with Phase 1.

These trials are vital to understanding how safe and effective a cancer drug is.

Dr. David Hong shares the importance of Phase 1 clinical trials and what to know before joining one. http://spr.ly/6008B8brDK

A Phase 1 clinical trial is the starting point for finding experimental drugs that can be used to treat cancer. But how do you know if one is right for you? David Hong, M.D., shares more about Phase 1 clinical trials, including who should consider participating and what to expect.

05/28/2026

What happens after remission?

That’s the next challenge researchers are working to answer. In relapsed B-cell acute lymphoblastic leukemia, measurable residual disease (MRD) may reveal cancer cells that remain even when standard tests show remission. Researchers are studying how identifying and treating this hidden disease could help reduce relapse and improve long-term outcomes.

This research will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and reflects ongoing efforts to better understand what comes next after remission for patients with leukemia.